VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $898,626 | -56.4% | 16,952 | -32.5% | 0.00% | -60.0% |
Q1 2024 | $2,058,938 | +23.3% | 25,109 | -72.0% | 0.01% | +66.7% |
Q4 2023 | $1,670,303 | +518.4% | 89,753 | +267.8% | 0.00% | +200.0% |
Q3 2023 | $270,108 | +25.3% | 24,400 | +83.5% | 0.00% | – |
Q2 2023 | $215,593 | -92.4% | 13,300 | -92.2% | 0.00% | -100.0% |
Q1 2023 | $2,839,508 | +182.4% | 170,541 | +59.5% | 0.01% | +100.0% |
Q4 2022 | $1,005,349 | +1029.6% | 106,952 | +226.3% | 0.00% | – |
Q3 2022 | $89,000 | -23.3% | 32,777 | +63.9% | 0.00% | -100.0% |
Q3 2020 | $116,000 | -37.3% | 20,000 | -22.1% | 0.00% | 0.0% |
Q2 2020 | $185,000 | +270.0% | 25,669 | +139.9% | 0.00% | – |
Q1 2020 | $50,000 | -96.5% | 10,700 | -94.0% | 0.00% | -100.0% |
Q4 2019 | $1,427,000 | +94.4% | 178,000 | +101.4% | 0.01% | +66.7% |
Q2 2019 | $734,000 | -61.8% | 88,400 | -54.3% | 0.01% | -60.0% |
Q1 2019 | $1,923,000 | +63.0% | 193,500 | +25.4% | 0.02% | +87.5% |
Q4 2018 | $1,180,000 | +164.6% | 154,303 | +502.8% | 0.01% | +300.0% |
Q3 2018 | $446,000 | +30.4% | 25,598 | -28.9% | 0.00% | 0.0% |
Q2 2018 | $342,000 | -58.2% | 35,987 | -80.8% | 0.00% | -60.0% |
Q1 2018 | $818,000 | – | 187,096 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |